ISDA

Deposition Date 2016-04-21

Release Date 2016-05-25

Last Version Date 2024-10-16

Entry Detail

PDB ID:

5JHU

Keywords:

Hydrolase/Hydrolase Inhibitor

Title:

Potent, Reversible MetAP2 Inhibitors via FBDD

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.18

R-Value Work:

0.13

R-Value Observed:

0.14

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Methionine aminopeptidase 2
Gene (Uniprot):METAP2
Chain IDs:A
Chain Length:369
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P50579 Pfam ID:PF00557 EC:3.4.11.18

Ligand Molecules

6KO

DMS

GOL

Primary Citation

Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design-Part 1.

Cheruvallath, Z, Tang, M, McBride, C, Komandla, M, Miura, J, Ton-Nu, T, Erikson, P, Feng, J, Farrell, P, Lawson, J.D, Vanderpool, D, Wu, Y, Dougan, D.R, Plonowski, A, Holub, C, Larson, C.Show

Bioorg.Med.Chem.Lett. 26 2774 2778 (2016)

PMID: 27155900 DOI: 10.1016/j.bmcl.2016.04.073

Abstact

Methionine aminopeptidase 2 (MetAP2) is an enzyme that cleaves an N-terminal methionine residue from a number of newly synthesized proteins. Pre-clinical and clinical studies suggest that MetAP2 inhibitors could be used as a novel treatment for obesity. Herein we describe our use of fragment screening methods and structural biology to quickly identify and elaborate an indazole fragment into a series of reversible MetAP2 inhibitors with <10nM potency, excellent selectivity, and favorable in vitro safety profiles.

Legend

Protein

Chemical

Disease

Primary Citation of related structures